{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:17:07Z","timestamp":1793578627276,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xphs.2022.12.022","type":"journal-article","created":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T09:14:09Z","timestamp":1672564449000},"page":"1166-1182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals"],"prefix":"10.1016","volume":"112","author":[{"given":"Stephen","family":"Horne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxma R.","family":"Nagavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilayat A.","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-0519","authenticated-orcid":false,"given":"Laurel","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yean Yean","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Lopes","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1115-5561","authenticated-orcid":false,"given":"Leticia Oyamada","family":"Sizukusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayrton Flavio Moura","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Bream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-7904","authenticated-orcid":false,"given":"David A.","family":"Keire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-0575","authenticated-orcid":false,"given":"Gary","family":"Condran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2022.12.022_bib0001","unstructured":"International-Council-for-Harmonisation-of-Technical-Requirements-for-Pharmaceuticals-for-Human-Use. 2017. ICH Harmonised Guideline: Assement and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk M7(R1). Current Step 4 version. https:\/\/database.ich.org\/sites\/default\/files\/M7_R1_Guideline.pdf Accessed 13 July 2022."},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cber.18760090131","article-title":"Ueber die Hydrazinverbindungen der Fettreihe","volume":"9","author":"Fischer","year":"1876","journal-title":"Ber Dtsch Chem Ges"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jlac.18631280203","article-title":"Ueber die Einwirkung von salpetrigsaurem Kali auf salzsaures Di\u00e4thylamin","volume":"128","author":"Geuther","year":"1863","journal-title":"Justus Liebigs Ann Chem"},{"key":"10.1016\/j.xphs.2022.12.022_bib0004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.15227\/orgsyn.016.0022","article-title":"unsym.-dimethylhydrazine hydrochloride","volume":"16","author":"Hatt","year":"1936","journal-title":"Org Synth"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/zfch.19680080202","article-title":"Synthesen des hydrazins und seiner alkylderivate","volume":"8","author":"Ohme","year":"1968","journal-title":"Zeitschrift f\u00fcr Chemie"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/ie50602a023","article-title":"Catalytic production of N, N-dimethylhydrazine","volume":"52","author":"Klager","year":"1960","journal-title":"Ind Eng Chem"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.022_bib0007","first-page":"167","article-title":"Some toxic properties of dimethylnitrosamine","volume":"11","author":"Barnes","year":"1954","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.xphs.2022.12.022_bib0008","series-title":"Some N-Nitroso Compounds IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans","year":"1978"},{"issue":"8","key":"10.1016\/j.xphs.2022.12.022_bib0009","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.7326\/0003-4819-10-8-1144","article-title":"Clinical manifestations and studies in parenchymatous hepatitis","volume":"10","author":"Freund","year":"1937","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bjc.1956.15","article-title":"The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine","volume":"10","author":"Magee","year":"1956","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00524152","article-title":"Organotrope carcinogene Wirkungen bei 65 verschiedenen N-nitroso-Verbindungen an BD-Ratten","volume":"69","author":"Druckrey","year":"1967","journal-title":"Zeitschrift f\u00fcr Krebsforschung"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.022_bib0012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/acs.chemrestox.1c00369","article-title":"Practical and science-based strategy for establishing acceptable intakes for drug product n-nitrosamine impurities","volume":"35","author":"Dobo","year":"2022","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.xphs.2022.12.022_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104749","article-title":"Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data","volume":"116","author":"Thresher","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"issue":"9","key":"10.1016\/j.xphs.2022.12.022_bib0014","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.3390\/ijms23094559","article-title":"Metabolic activation and DNA interactions of carcinogenic n-nitrosamines to which humans are commonly exposed","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2022.12.022_bib0015","series-title":"Chemical Carcinogens","first-page":"643","article-title":"N-Nitroso carcinogens","author":"Preussmann","year":"1984"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.022_bib0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/00498257309151524","article-title":"Specific carcinogenic and teratogenic effects of \u2018indirect\u2019 alkylating methyl and ethyl compounds, and their dependency on stages of ontogenic developments","volume":"3","author":"Druckrey","year":"1973","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00365976","article-title":"Carcinogenic N-nitroso compounds and their environmental significance","volume":"71","author":"Preussmann","year":"1984","journal-title":"Naturwissenschaften"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.022_bib0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bcpt.12054","article-title":"Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs","volume":"112","author":"Brambilla","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.022_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1081\/DCT-120024844","article-title":"Genotoxic activities of drug-nitrite interaction products","volume":"26","author":"Ozhan","year":"2003","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.xphs.2022.12.022_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-022-03347-6","article-title":"Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s","author":"Li","year":"2022","journal-title":"Arch Toxicol"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.022_bib0021","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0015-6264(68)90292-7","article-title":"Occurrence of nitrosamines in foodstuffs for human and animal consumption","volume":"6","author":"Ender","year":"1968","journal-title":"Food Cosmet Toxicol"},{"issue":"4990","key":"10.1016\/j.xphs.2022.12.022_bib0022","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/2061261b0","article-title":"Dimethylnitrosamine; its hepatotoxic effect in sheep and its occurrence in toxic batches of herring meal","volume":"206","author":"Sakshaug","year":"1965","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.022_bib0023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-6147(87)90164-7","article-title":"The enigma of the organspecificity of carcinogenic nitrosamines","volume":"8","author":"Preussmann","year":"1987","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.xphs.2022.12.022_bib0024","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chemosphere.2018.07.098","article-title":"Critical review of major sources of human exposure to N-nitrosamines","volume":"210","author":"Gushgari","year":"2018","journal-title":"Chemosphere"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.022_bib0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00008469-199706000-00003","article-title":"N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids","volume":"6","author":"Tricker","year":"1997","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.xphs.2022.12.022_bib0026","series-title":"Six-Year Review 3 Technical Support Document for Nitrosamines","year":"2016"},{"issue":"9","key":"10.1016\/j.xphs.2022.12.022_bib0027","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.3390\/ijms23094559","article-title":"Metabolism and DNA adduct formation of tobacco-specific N-nitrosamines","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5368","key":"10.1016\/j.xphs.2022.12.022_bib0028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/239165b0","article-title":"Carcinogenic nitrosamines formed by drug\/nitrite interactions","volume":"239","author":"Lijinsky","year":"1972","journal-title":"Nature"},{"issue":"67","key":"10.1016\/j.xphs.2022.12.022_bib0029","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/newbio236177a0","article-title":"Carcinogen dimethylnitrosamine produced in vivo from nitrite and aminopyrine","volume":"236","author":"Lijinsky","year":"1972","journal-title":"Nat New Biol"},{"issue":"6","key":"10.1016\/j.xphs.2022.12.022_bib0030","first-page":"867","article-title":"Carcinogenic N-nitrosodimethylamine as a contamination in drugs containing 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one (amidopyrine, aminophenazone)","volume":"29","author":"Eisenbrand","year":"1979","journal-title":"Arzneim-Forsch"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0096","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0041-008X(77)90124-7","article-title":"N-Nitroso derivatives of hydrochlorothiazide, niridazole, and tolbutamide","volume":"40","author":"Gold","year":"1977","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.022_bib0031","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1208\/s12248-020-00473-w","article-title":"A cautionary tale: quantitative LC-HRMS analytical procedures for the analysis of N-nitrosodimethylamine in metformin","volume":"22","author":"Yang","year":"2020","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2022.12.022_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113582","article-title":"HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products","volume":"191","author":"Alshehri","year":"2020","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.022_bib0033","first-page":"554","article-title":"Analysis of selected drug formulations for volatile nitrosamines","volume":"70","author":"Dawson","year":"1987","journal-title":"J Assoc Off Anal Chem"},{"key":"10.1016\/j.xphs.2022.12.022_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106026","article-title":"NDMA analytics in metformin products: comparison of methods and pitfalls","volume":"168","author":"Fritzsche","year":"2022","journal-title":"Eur J Pharm Sci"},{"issue":"22","key":"10.1016\/j.xphs.2022.12.022_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225304","article-title":"N-nitrosodimethylamine contamination in the metformin finished products","volume":"25","author":"Zmyslowski","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2022.12.022_bib0036","series-title":"10\/2\/19: UPDATE - FDA Provides Update on Testing of Ranitidine for NDMA Impurities","year":"2019"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.022_bib0037","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1208\/s12248-022-00702-4","article-title":"International regulatory collaboration on the analysis of nitrosamines in metformin-containing medicines","volume":"24","author":"Keire","year":"2022","journal-title":"AAPS J"},{"issue":"12","key":"10.1016\/j.xphs.2022.12.022_bib0038","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.xphs.2021.08.010","article-title":"Inhibition of N-nitrosamine formation in drug products: a model study","volume":"110","author":"Nanda","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.12.022_bib0039","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jpba.2018.11.010","article-title":"NDMA impurity in valsartan and other pharmaceutical products: analytical methods for the determination of N-nitrosamines","volume":"164","author":"Parr","year":"2019","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"10.1016\/j.xphs.2022.12.022_bib0040","first-page":"870","article-title":"N-Nitroso compound contaminants in prescription and nonprescription drugs","volume":"29","author":"Krull","year":"1979","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.xphs.2022.12.022_bib0041","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0015-6264(81)90455-7","article-title":"Analysis of volatile N-nitrosamines in commercial drugs","volume":"19","author":"Castegnaro","year":"1981","journal-title":"Food Cosmet Toxicol"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0042","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0041-008X(85)90075-4","article-title":"Formation of N-mononitrosopiperazine in the stomach and its excretion in the urine after oral intake of piperazine","volume":"80","author":"Bellander","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.xphs.2022.12.022_bib0043","series-title":"Indapamide monograph 1108, Ph. Eur","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0044","series-title":"Gliclazide monograph 1524, Ph. Eur","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0045","series-title":"Molsidomine monograph 1701, Ph. Eur","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0046","series-title":"Trolamine monograph 1577, Ph. Eur","year":"2022"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0047","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.watres.2010.09.036","article-title":"Demonstration of 20 pharmaceuticals and personal care products (PPCPs) as nitrosamine precursors during chloramine disinfection","volume":"45","author":"Shen","year":"2011","journal-title":"Water Res"},{"key":"10.1016\/j.xphs.2022.12.022_bib0048","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jes.2017.05.028","article-title":"Characterization of N-nitrosodimethylamine formation from the ozonation of ranitidine","volume":"58","author":"Ly","year":"2017","journal-title":"J Environ Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.022_bib0049","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1021\/acs.joc.0c02774","article-title":"An organic chemist's guide to N-nitrosamines: their structure, reactivity, and role as contaminants","volume":"86","author":"Beard","year":"2021","journal-title":"J Org Chem"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mrrev.2006.09.003","article-title":"Genotoxic and carcinogenic risk to humans of drug\u2013nitrite interaction products","volume":"635","author":"Brambilla","year":"2007","journal-title":"Mutat Res\/Rev Mutat Res"},{"issue":"2-3","key":"10.1016\/j.xphs.2022.12.022_bib0051","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mrrev.2008.09.002","article-title":"Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals","volume":"681","author":"Brambilla","year":"2009","journal-title":"Mutat Res"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.022_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100435","article-title":"Risk assessment for nitrosated pharmaceuticals: a future perspective in drug development","volume":"355","author":"Schmidtsdorff","year":"2022","journal-title":"Arch Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2022.12.022_bib0053","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18253","article-title":"In vitro analysis of N-Nitrosodimethylamine (NDMA) formation from ranitidine under simulated gastrointestinal conditions","volume":"4","author":"Gao","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.xphs.2022.12.022_bib0054","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0278-6915(85)90286-8","article-title":"Susceptibilities of drugs to nitrosation under simulated gastric conditions","volume":"23","author":"Gillatt","year":"1985","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.022_bib0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jama.2021.9199","article-title":"Effect of oral ranitidine on urinary excretion of N-nitrosodimethylamine (NDMA): a randomized clinical trial","volume":"326","author":"Florian","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.xphs.2022.12.022_bib0056","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(05)70257-6","article-title":"Keynote comment: nitrosatable drugs, cancer, and guidelines for genotoxicity","volume":"6","author":"Brambilla","year":"2005","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0057","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yrtph.2007.06.008","article-title":"An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals","volume":"49","author":"Delaney","year":"2007","journal-title":"Regul Toxicol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2022.12.022_bib0058","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acs.oprd.0c00323","article-title":"Pathways for N-nitroso compound formation: secondary amines and beyond","volume":"24","author":"L\u00f3pez-Rodr\u00edguez","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.12.022_bib0059","series-title":"Product Class 4: N-Nitrosoamines. Category 5, Compounds with One Saturated Carbon Heteroatom Bond Nitro, Nitroso, Azo, Azoxy, and Diazonium Compounds, Azides, Triazenes, and Tetrazenes","first-page":"437","author":"Boysen","year":"2010"},{"issue":"24","key":"10.1016\/j.xphs.2022.12.022_bib0060","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1080\/10643389.2018.1430438","article-title":"Toward N-nitrosamines free water: Formation, prevention, and removal","volume":"47","author":"Alaba","year":"2017","journal-title":"Crit Rev Environ Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0061","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1070\/RC1971v040n01ABEH001894","article-title":"Advances in the chemistry of aliphatic N-nitrosamines","volume":"40","author":"Fridman","year":"1971","journal-title":"Russ Chem Rev"},{"issue":"2-3","key":"10.1016\/j.xphs.2022.12.022_bib0062","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00304948709356181","article-title":"Recent synthetic applications of N-nitrosamines and related compounds","volume":"19","author":"Saavedra","year":"1987","journal-title":"Org Prep Proced Int"},{"issue":"38","key":"10.1016\/j.xphs.2022.12.022_bib0063","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/S0040-4039(00)78747-8","article-title":"Isolation and characterization of N-alkyl-N- (hydroxymethyl)nitrosamines from N-alkyl-N- (hydroperoxymethyl)nitrosamines by deoxygenation","volume":"21","author":"Mochizuki","year":"1980","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.xphs.2022.12.022_bib0064","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1039\/p29840001963","article-title":"Nitrite ion as a nitrosating reagent. Nitrosation of morpholine and diethylamine in the presence of formaldehyde","volume":"2","author":"Casado","year":"1984","journal-title":"J Chem Soc Perkin Trans"},{"issue":"4106","key":"10.1016\/j.xphs.2022.12.022_bib0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1126\/science.181.4106.1245","article-title":"N-nitrosation by nitrite ion in neutral and basic medium","volume":"181","author":"Keefer","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.xphs.2022.12.022_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.meatsci.2020.108272","article-title":"Chemistry, safety, and regulatory considerations in the use of nitrite and nitrate from natural origin in meat products - Invited review","volume":"171","author":"Flores","year":"2021","journal-title":"Meat Sci"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0067","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.2050-0416.1986.tb04373.x","article-title":"The chemistry of niitrosamine formation: relevance to malting and brewing","volume":"92","author":"Wainright","year":"1986","journal-title":"J Inst Brew"},{"issue":"9","key":"10.1016\/j.xphs.2022.12.022_bib0069","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1021\/acs.oprd.0c00224","article-title":"Potential for the formation of N-nitrosamines during the manufacture of active pharmaceutical ingredients: an assessment of the risk posed by trace nitrite in water","volume":"24","author":"Ashworth","year":"2020","journal-title":"Org Process Res Dev"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.022_bib0070","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","article-title":"Reactive impurities in excipients: profiling, identification and mitigation of drug\u2013excipient incompatibility","volume":"12","author":"Wu","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2022.12.022_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121687","article-title":"Nitrocellulose blister material as a source of N-nitrosamine contamination of pharmaceutical drug products","volume":"618","author":"Golob","year":"2022","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0072","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5731\/pdajpst.2021.012645","article-title":"Evaluating nitrosamines from elastomers in pharmaceutical primary packaging","volume":"76","author":"Boltres","year":"2022","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2022.12.022_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.782536","article-title":"The EU response to the presence of nitrosamine impurities in medicines","volume":"8","author":"Ruepp","year":"2021","journal-title":"Front Med"},{"issue":"9","key":"10.1016\/j.xphs.2022.12.022_bib0074","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.xphs.2021.04.021","article-title":"Nitrosamine contamination in pharmaceuticals: threat, impact, and control","volume":"110","author":"Tuesuwan","year":"2021","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.022_bib0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12249-019-1376-1","article-title":"Lesson learnt from recall of valsartan and other angiotensin ii receptor blocker drugs containing NDMA and NDEA impurities","volume":"20","author":"Charoo","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.xphs.2022.12.022_bib0076","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/es903916t","article-title":"Unexpected role of activated carbon in promoting transformation of secondary amines to N-nitrosamines","volume":"44","author":"Padhye","year":"2010","journal-title":"Environ Sci Technol"},{"issue":"13","key":"10.1016\/j.xphs.2022.12.022_bib0077","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1016\/j.watres.2013.04.050","article-title":"Formation, precursors, control, and occurrence of nitrosamines in drinking water: a review","volume":"47","author":"Krasner","year":"2013","journal-title":"Water Res"},{"key":"10.1016\/j.xphs.2022.12.022_bib0079","unstructured":"2020. European Medicines Agency. Lessons learnt from presence of N-nitrosamine impurities in sartan medicines. Overview and recommendations."},{"issue":"7","key":"10.1016\/j.xphs.2022.12.022_bib0086","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/acs.oprd.9b00270","article-title":"Regulatory Highlights","volume":"23","author":"Teasdale","year":"2019","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.12.022_bib0088","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.oprd.0c00462","article-title":"Ranitidine - investigations into the root cause for the presence of N\u2011nitroso\u2011N,N\u2011dimethylamine in ranitidine hydrochloride drug substances and associated drug products","volume":"24","author":"King","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.12.022_bib0082","series-title":"Sildenafil citrate monograph 2270, Ph. Eur","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0083","series-title":"Venlafaxine Hydrochloride monograph 2119, Ph. Eur","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0084","first-page":"181","article-title":"Nitrosation of bromhexine","volume":"16","author":"Conrad","year":"1990","journal-title":"Drug Dev Eval"},{"key":"10.1016\/j.xphs.2022.12.022_bib0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jpba.2017.10.035","article-title":"Artifactual degradation of secondary amine-containing drugs during accelerated stability testing when saturated sodium nitrite solutions are used for humidity control","volume":"149","author":"Sluggett","year":"2018","journal-title":"J Pharm Biomed Anal"},{"issue":"21","key":"10.1016\/j.xphs.2022.12.022_bib0098","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1021\/j100358a024","article-title":"MCSCF study of the rearrangement of nitromethane to methyl nitrite","volume":"93","author":"McKee","year":"1989","journal-title":"J Phys Chem"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0078","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/em.2850170109","article-title":"Aerial oxidation of hydrazines to nitrosamines","volume":"17","author":"Lunn","year":"1991","journal-title":"Environ Mol Mutagen"},{"issue":"40","key":"10.1016\/j.xphs.2022.12.022_bib0068","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1016\/S0040-4039(00)88318-5","article-title":"Rapid nitrosamine formation from a tertiary amine: the nitrosation of 2-(N,N-Dimethylaminomethyl)pyrrole","volume":"24","author":"Loeppky","year":"1983","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.xphs.2022.12.022_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113573","article-title":"HILIC-MS determination of dimethylamine in the active pharmaceutical ingredients and in the dosage forms of metformin","volume":"191","author":"Dousa","year":"2020","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15287398509530632","article-title":"Formation of DNA-damaging nitroso compounds by interaction of drugs with nitrite. A preliminary screening for detecting potentially hazardous drugs","volume":"15","author":"Brambilla","year":"1985","journal-title":"J Toxicol Environ Health"},{"key":"10.1016\/j.xphs.2022.12.022_bib0081","series-title":"Metformin Hydrochloride monograph 0931, Ph. Eur","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0090","series-title":"Monograph for Orphenadrine Citrate","year":"2022"},{"issue":"40","key":"10.1016\/j.xphs.2022.12.022_bib0091","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1016\/S0040-4039(00)88318-5","article-title":"Rapid nitrosamine formation from a tertiary amine: the nitrosation of 2-(N,N-dimethylaminomethyl)pyrrole","volume":"24","author":"Loeppky","year":"1983","journal-title":"Tetrahedron Lett"},{"issue":"11","key":"10.1016\/j.xphs.2022.12.022_bib0092","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0278-6915(87)90266-3","article-title":"Identification of minor nitrosation products of the alkaloid gramine by mass spectrometry","volume":"25","author":"Ahmad","year":"1987","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.xphs.2022.12.022_bib0093","series-title":"Nitrosation Reactions and the Chemistry of Nitric Oxide","first-page":"280","year":"2004"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0094","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mrrev.2006.09.003","article-title":"Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products","volume":"635","author":"Brambilla","year":"2007","journal-title":"Mutat Res Rev Mutat Res"},{"key":"10.1016\/j.xphs.2022.12.022_bib0095","series-title":"Nitrosation of Drugs","first-page":"291","author":"Eisenbrand","year":"1981"},{"issue":"20","key":"10.1016\/j.xphs.2022.12.022_bib0099","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1021\/es3023094","article-title":"NDMA Formation by chloramination of ranitidine: kinetics and mechanism","volume":"46","author":"Le Roux","year":"2012","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.xphs.2022.12.022_bib0100","series-title":"AWWA Water Quality Technology Conference & Exposition","author":"Le Roux","year":"2012"},{"issue":"8255","key":"10.1016\/j.xphs.2022.12.022_bib0101","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(81)91328-3","article-title":"Safety of ranitidine","volume":"2","author":"Brittain","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.xphs.2022.12.022_bib0102","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1039\/p19870000951","article-title":"Isolation and identification of the hydrolytic degradation products of ranitidine hydrochloride","volume":"1","author":"Haywood","year":"1987","journal-title":"J Chem Soc Perkin Trans"},{"issue":"15","key":"10.1016\/j.xphs.2022.12.022_bib0103","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1021\/es500997e","article-title":"Formation mechanism of NDMA from ranitidine, trimethylamine, and other tertiary amines during chloramination: a computational study","volume":"48","author":"Liu","year":"2014","journal-title":"Environ Sci Technol"},{"issue":"10","key":"10.1016\/j.xphs.2022.12.022_bib0104","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1248\/cpb.c20-00431","article-title":"Temperature-dependent formation of N-nitrosodimethylamine during the storage of ranitidine reagent powders and tablets","volume":"68","author":"Abe","year":"2020","journal-title":"Chem Pharm Bull"},{"issue":"9","key":"10.1016\/j.xphs.2022.12.022_bib0105","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1248\/cpb.c21-00289","article-title":"N-Nitrosodimethylamine (NDMA) formation from ranitidine impurities: possible root causes of the presence of NDMA in ranitidine hydrochloride","volume":"69","author":"Yokoo","year":"2021","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.xphs.2022.12.022_bib0106","series-title":"Pfizer Voluntary Nationwide Recall of Lots of ACCUPRIL\u00ae (Quinapril HCl) Due to N-Nitroso-Quinapril Content","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0107","series-title":"FDA Updates and Press Announcements on Nitrosamine in Varenicline (Chantix)","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0108","series-title":"Nitrosamine drug substance-related impurities (NDSRIs). European Pharmaceutical Review","author":"Elder","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0109","series-title":"Meglumine monograph 2055, Ph. Eur","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0110","article-title":"A nitrite excipient database: a useful tool to support N-nitrosamine risk assessments for drug products","author":"Boetzel","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.12.022_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121740","article-title":"Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite","volume":"620","author":"Schlingemann","year":"2022","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.022_bib0112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1289\/ehp.02110145","article-title":"Nitrous acid, nitrogen dioxide, and ozone concentrations in residential environments","volume":"110","author":"Lee","year":"2002","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.xphs.2022.12.022_bib0113","series-title":"FDA Updates and Press Announcements on NDMA in Metformin","year":"2021"},{"key":"10.1016\/j.xphs.2022.12.022_bib0114","series-title":"Amitriptyline Antidepressant Drugs Recalled Because of a Nitrosamine Impurity","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0115","series-title":"Questions and Answers for marketing authorisation Holders\/Applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726\/2004 Referral on Nitrosamine Impurities in Human Medicinal Products","year":"2022"},{"key":"10.1016\/j.xphs.2022.12.022_bib0116","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2017.11.052","article-title":"Ghost peak\" of clofazimine: a solution degradation product of clofazimine via nucleophilic substitution by nitrite leaching from certain glass HPLC vials","volume":"150","author":"Lin","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2022.12.022_bib0117","series-title":"N-Nitroso Compounds: Occurrence and Biological Effects","first-page":"231","article-title":"Nitrosamines and rubber","author":"Spiegelhalder","year":"1982"},{"issue":"6","key":"10.1016\/j.xphs.2022.12.022_bib0118","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0015-6264(82)80232-0","article-title":"Estimation of volatile N-nitrosamines in rubber nipples for babies' bottles","volume":"20","author":"Havery","year":"1982","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"10.1016\/j.xphs.2022.12.022_bib0119","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4236\/ajac.2013.46035","article-title":"Analysis of N-nitrosamine migration from rubber teats and soothers","volume":"4","author":"Mutsuga","year":"2013","journal-title":"Am J Anal Chem"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.022_bib0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00005344-198401000-00018","article-title":"The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro-inhibition of 12-HPETE biosynthesis","volume":"6","author":"Darius","year":"1984","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.xphs.2022.12.022_bib0121","series-title":"ICH Harmonised Tripartate Guideline: Pharmaceutical Quality System Q10. Current Step 4 version","year":"2008"},{"key":"10.1016\/j.xphs.2022.12.022_bib0122","series-title":"ICH Harmonised Tripartate Guideline: Quality Risk Management Q9. Current Step 4 version","year":"2005"},{"key":"10.1016\/j.xphs.2022.12.022_bib0123","series-title":"ICH Harmonised Tripartite Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q7","year":"2000"},{"key":"10.1016\/j.xphs.2022.12.022_bib0124","series-title":"Analysis and Formation of Disinfection Byproducts in Drinking Water","first-page":"85","article-title":"Ozonation in drinking water treatment: an overview of general and practical aspects, mechanism, kinetics, and byproduct formation","author":"Manasfi","year":"2021"},{"issue":"8","key":"10.1016\/j.xphs.2022.12.022_bib0125","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/acs.oprd.1c00162","article-title":"Nitrosamine reactivity: a survey of reactions and purge processes","volume":"25","author":"Borths","year":"2021","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.12.022_bib0126","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1039\/JR9590002943","article-title":"Mechanism of the azide\u2013nitrite reaction. Part I","author":"Stedman","year":"1959","journal-title":"J Chem Soc"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922006141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922006141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:43:06Z","timestamp":1758361386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922006141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":124,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0022354922006141"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.12.022","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}